HUP0202764A3 - Floating pharmaceutical composition comprising an active phase and a non-active phase - Google Patents

Floating pharmaceutical composition comprising an active phase and a non-active phase

Info

Publication number
HUP0202764A3
HUP0202764A3 HU0202764A HUP0202764A HUP0202764A3 HU P0202764 A3 HUP0202764 A3 HU P0202764A3 HU 0202764 A HU0202764 A HU 0202764A HU P0202764 A HUP0202764 A HU P0202764A HU P0202764 A3 HUP0202764 A3 HU P0202764A3
Authority
HU
Hungary
Prior art keywords
active phase
pharmaceutical composition
floating pharmaceutical
floating
active
Prior art date
Application number
HU0202764A
Other languages
English (en)
Original Assignee
Galenix Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galenix Dev filed Critical Galenix Dev
Publication of HUP0202764A2 publication Critical patent/HUP0202764A2/hu
Publication of HUP0202764A3 publication Critical patent/HUP0202764A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
HU0202764A 1999-08-06 2000-08-02 Floating pharmaceutical composition comprising an active phase and a non-active phase HUP0202764A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9910285A FR2797185B1 (fr) 1999-08-06 1999-08-06 Composition pharmaceutique flottante comprenant une phase active et une phase non active
PCT/FR2000/002223 WO2001010417A1 (fr) 1999-08-06 2000-08-02 Composition pharmaceutique flottante comprenant une phase active et une phase non active

Publications (2)

Publication Number Publication Date
HUP0202764A2 HUP0202764A2 (hu) 2003-01-28
HUP0202764A3 true HUP0202764A3 (en) 2004-05-28

Family

ID=9548990

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0202764A HUP0202764A3 (en) 1999-08-06 2000-08-02 Floating pharmaceutical composition comprising an active phase and a non-active phase

Country Status (12)

Country Link
US (1) US7682629B1 (hu)
EP (1) EP1206247B1 (hu)
AT (1) ATE450254T1 (hu)
AU (1) AU779036B2 (hu)
BR (1) BR0013106A (hu)
CA (1) CA2378988C (hu)
DE (1) DE60043442D1 (hu)
FR (1) FR2797185B1 (hu)
HU (1) HUP0202764A3 (hu)
IL (2) IL148003A0 (hu)
NO (1) NO20020572L (hu)
WO (1) WO2001010417A1 (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0211317A (pt) 2001-07-04 2004-12-14 Sun Pharmaceutical Ind Ltd Sistema para a liberação controlada de uma droga por meio de retenção gástrica
ES2530791T3 (es) * 2002-12-20 2015-03-05 Hoffmann La Roche Formulación de ibandronato de altas dosis
TW200533391A (en) 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
BRPI0615410A2 (pt) * 2005-08-30 2013-02-13 Nicholas Piramal India Ltd composiÇço farmacÊutica de liberaÇço prolongada de metformina e processo para produÇço da mesma
JP5545952B2 (ja) * 2007-08-31 2014-07-09 第一三共株式会社 徐放性製剤及びその製造方法
KR20110042366A (ko) 2008-08-18 2011-04-26 팀 아카데미 오브 파마슈티컬 사이언스 위장체류 약물 전달 시스템, 제작 방법 및 그것들의 사용
FR2938431B1 (fr) 2008-11-14 2013-12-20 Debregeas Et Associes Pharma Nouvelle composition a base d'acide gamma-hydroxybutyrique
FR2949062B1 (fr) 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
FR2949061B1 (fr) * 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
FR2967352B1 (fr) * 2010-11-12 2012-12-28 Unither Dev Comprime effervescent pour l'administration par voie orale de principes actifs
US10172794B2 (en) 2013-12-13 2019-01-08 Biogen Ma Inc. Controlled release dosage form for once daily administration of dimethyl fumarate
US11666546B2 (en) 2017-12-18 2023-06-06 Tris Pharma, Inc GHB pharmaceutical compositions comprising a floating interpenetrating polymer network forming system
AU2018388577B2 (en) * 2017-12-18 2024-06-06 Tris Pharma, Inc. Modified release drug powder composition comprising gastro-retentive raft forming systems having trigger pulse drug release
US12514818B2 (en) 2017-12-18 2026-01-06 Tris Pharma, Inc. Pharmaceutical compositions comprising a floating interpenetrating polymer network forming system
US11337920B2 (en) 2017-12-18 2022-05-24 Tris Pharma, Inc. Pharmaceutical composition comprising GHB gastro-retentive raft forming systems having trigger pulse drug release
CN121038779A (zh) 2023-02-03 2025-11-28 特瑞斯制药公司 每晚一次的低钠羟丁酸盐组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
JPS62195323A (ja) * 1986-02-24 1987-08-28 Eisai Co Ltd 胃内滞留型粒子
DE3803482A1 (de) * 1988-02-05 1989-08-17 Lohmann Therapie Syst Lts Schwimmfaehiges orales therapeutisches system
DE4403943A1 (de) * 1994-02-08 1995-08-10 Hexal Pharma Gmbh Orale Azrneimittelzubereitung mit Diclofenac-Natrium
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
US5783212A (en) * 1996-02-02 1998-07-21 Temple University--of the Commonwealth System of Higher Education Controlled release drug delivery system
IT1282650B1 (it) * 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
FR2766708B1 (fr) * 1997-07-30 2000-05-05 Galenix Dev Composition contenant de l'hydroxypropylcellulose, de l'hydroxypropylmethylcellulose et/ou de l'ethylcellullose a titre d'agents desintegrants, et procede d'obtention
US6197328B1 (en) * 1999-08-20 2001-03-06 Dott Research Laboratory Nasally administrable compositions

Also Published As

Publication number Publication date
AU6848700A (en) 2001-03-05
EP1206247B1 (fr) 2009-12-02
US7682629B1 (en) 2010-03-23
AU779036B2 (en) 2005-01-06
IL148003A (en) 2007-06-03
EP1206247A1 (fr) 2002-05-22
IL148003A0 (en) 2002-09-12
CA2378988A1 (fr) 2001-02-15
NO20020572D0 (no) 2002-02-05
NO20020572L (no) 2002-04-03
WO2001010417A1 (fr) 2001-02-15
CA2378988C (fr) 2012-04-17
BR0013106A (pt) 2002-07-23
ATE450254T1 (de) 2009-12-15
HUP0202764A2 (hu) 2003-01-28
FR2797185A1 (fr) 2001-02-09
DE60043442D1 (de) 2010-01-14
FR2797185B1 (fr) 2001-10-26

Similar Documents

Publication Publication Date Title
EG24411A (en) Pharmaceutically active compounds
GB9924020D0 (en) Pharmaceutically active compounds
SG115489A1 (en) Pharmaceutically active morpholinol
IL146117A0 (en) New pharmaceutically active compounds
PT1200118E (pt) Formulação farmacêutica compreendendo melagatrano e seu pró-fármaco
EP1109541B8 (de) Folienförmige wirkstoffträger
AU2792700A (en) Pharmaceutical composition containing cyclosporin
AU1730201A (en) Proteoglycans and pharmaceutical compositions comprising them
AU1702500A (en) Utilization of a magneto-resistive material
IL131266A0 (en) Peptides and pharmaceutical compositions comprising same
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof
HUP0105097A3 (en) Pharmaceutical mixtures comprising a combination of a profen and other active compounds
GB9909154D0 (en) Pharmaceutical formulation
GB9926251D0 (en) Pharmaceutical formulation
AU4504201A (en) Drug preparations
SI1200118T1 (sl) Farmacevtska formulacija, ki obsega megalatran innjegovo predzdravilo
AU7655700A (en) Medicament combinations
GB9924028D0 (en) Pharmaceutically active compounds
GB9924041D0 (en) Pharmaceutically active compounds
HU0300437D0 (en) Pharmaceutically active morpholinol derivatives
GB9906129D0 (en) Placebo none cigarett
CA88762S (en) Pharmaceutical tablet
GB9801230D0 (en) Pharmaceutically active morpholinol
IL158978A0 (en) Pharmaceutically active morpholinol
GB9926434D0 (en) Pharmaceutical

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished